INOVIQ LTD

CelLBxHealth plc, formerly known as ANGLE plc until its name change in October 2025, is a medical diagnostics enterprise established in 1994 and headquartered in Guildford, United Kingdom. The company is dedicated to developing advanced cancer diagnostic products, serving markets across the United Kingdom, Europe, North America, and other international regions. Its core offerings include the Parsortix PC1 and PR1 systems, which are innovative medical devices engineered to capture and retrieve intact circulating tumor cells (CTCs) from patient blood. Specifically, the PC1 system is designed for metastatic breast cancer samples, facilitating subsequent user-validated downstream analysis. CelLBxHealth also provides the Portrait+ CTC Staining kit, a laboratory solution for the identification, characterization, and enumeration of epithelial and mesenchymal CTCs with high analytical sensitivity and specificity, alongside the CellKeep Slide technology for CTC harvesting. In addition to these products, the company delivers a suite of laboratory services, including CTC enrichment and liquid biopsy analysis. Specialized assays are also available, such as Portrait Flex for immunofluorescence-based identification of epithelial, mesenchymal, and epithelial-to-mesenchymal transition, Portrait PD-L1 for CTC evaluation, and bespoke custom CTC assays. Furthermore, CelLBxHealth plc has forged strategic alliances, including a partnership with BioView Ltd to co-develop a human epidermal growth factor receptor 2 (HER2) assay kit for breast cancer, and an agreement with NuProbe USA, Inc. for the application of its pan-cancer next-generation sequencing (NGS) panel.

AnchorDxMedical DeviceChina

62% match

AnchorDx is a public biotechnology company headquartered in Guangzhou, China, with additional research and production facilities in the United States. The company specializes in the development of advanced cancer screening and early diagnostic solutions utilizing genomic and molecular technologies. Their products target precision medicine and oncology markets globally.

Tvaster GenkalpTherapeutic DevicesIndia

61% match

Tvaster Genkalp Pvt. Ltd. is a molecular diagnostics company established in May 2021 and headquartered in Chennai, Tamil Nadu. The company specializes in liquid biopsy, offering blood-based cancer diagnostic solutions.

IMAGION BIOSYSTEMS LIMITEDIBX · Health Care Equipment & ServicesMelbourne, Australia

65% matchPublic

Imagion Biosystems Limited operates as a medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases in Australia. The company is involved in nanotechnology; biotechnology; medical imaging using magnetic resonance; and cancer diagnostics businesses. It develops MagSense, which is in Phase 2 for the treatment of HER2 breast cancers, as well as advancing the research and development programs for prostate and ovarian cancer. It also develops PrecisionMRX, an iron oxide nanoparticle to magnetic relaxometry. The company has collaboration agreement with Wayne State University to develop optimised MRI sequences which is in Phase 2 study of for the MagSense imaging agent. Imagion Biosystems Limited was incorporated in 2016 and is based in Melbourne, Australia.

Rhythm Biosciences Limited functions as a forward-thinking enterprise focused on predictive cancer diagnostics, active across both Australian and global territories. The company's core operations involve the creation, advancement, and market introduction of cutting-edge medical diagnostic technologies. A key innovation is ColoSTAT, their specialized blood test designed for the prompt and reliable identification of colorectal cancer. Established in 2017, the firm's main offices are located in Parkville, Australia.

VISIONFLEX GROUP LIMITEDVFX · Health Care Equipment & ServicesWarriewood, Australia

63% matchPublic

Operating in Australia, Visionflex Group Limited and its associated companies specialize in providing cutting-edge healthcare, telehealth, and remote diagnostic services. The company's portfolio features virtual healthcare systems and specialized medical peripherals, which are seamlessly integrated with its custom-developed software to enable efficient remote diagnostics and patient management. Furthermore, Visionflex facilitates online search and appointment scheduling for both medical practitioners and corporate entities. Founded in 2009 and based in Warriewood, Australia, the organization was formerly known as 1st Group Limited until its rebranding as Visionflex Group Limited in November 2023.